<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03355352</url>
  </required_header>
  <id_info>
    <org_study_id>277/2017BO1</org_study_id>
    <nct_id>NCT03355352</nct_id>
  </id_info>
  <brief_title>Observational Study of Analgesia and Cost-efficiency of Analgetic Medication Pumps (Zalviso and PCA-syringe Pump (PCA=Patient Controlled Analgesia)) After Urogenital Intervention at the Clinical Daily Routine</brief_title>
  <official_title>Observational Study of Analgesia and Cost-efficiency of Analgetic Medication Pumps (Zalviso and PCA-syringe Pump) After Urogenital Intervention at the Clinical Daily Routine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The observational study will check if there is a difference in the postoperative care of
      patients with urogenital intervention while using the standard PCA-syringe pump or using the
      Zalviso sufentanyl sublingual analgetic system.

      The study will exactly examine, using questionaire for the patient, the medical stuff (nurses
      and anesthesiologist) the difference in the analgetic quality, the difference of the
      patients` mobility while being treated with one of the analgetic system and if there is a
      difference in the cost-efficiency.

      We want to examine 50 Patients in each group. The studies should be finished in about one
      year.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic quality</measure>
    <time_frame>1 year</time_frame>
    <description>Recording of the analgesic quality measured by the request of more analgesic postoperative while being treated with the conventional PCA or the Zalviso system.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mobility</measure>
    <time_frame>1 year</time_frame>
    <description>Recording of the patients mobility postoperative while being treated with the conventional PCA or the Zalviso system.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>medical cost efficiency</measure>
    <time_frame>1 year</time_frame>
    <description>Comparison of the cost efficiency of both systems</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Analgesic Quality</condition>
  <condition>Mobility</condition>
  <arm_group>
    <arm_group_label>Patients treated with conventional i.v. PCA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients treated with Zalviso</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil</intervention_name>
    <description>Sufentail sublingual 15ug nanopills</description>
    <arm_group_label>Patients treated with Zalviso</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients at the teaching hospital of university tuebingen which get an surgical
        urological intervention and which correspond with the inclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients after urological interventions with no indication of an periduralanästesia

          -  Patients compliant for a PCA system, and complied with the analysis of their data

        Exclusion Criteria:

          -  F03 dementia

          -  F10.2 dependence syndrome alcohol

          -  F11.2 dependence syndrome opioids

          -  F12.2 dependence syndrome cannabinoids

          -  F13.2 dependence syndrome sedatives and hypnotics

          -  F14.2 dependence syndrome cocaine

          -  F15.2 dependence syndrome coffin

          -  F.16.2 dependence syndrome hallucinogens

          -  F22 schizophrenia

          -  F41.1 generalized anxiety disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Barbara Schlisio, Dr. med.</last_name>
    <phone>07071/2985612</phone>
    <email>barbara.schlisio@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fabian Kreß</last_name>
    <email>Fabian.kress@student.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Tuebingen, clinic of anästhesiology and intensiv care</name>
      <address>
        <city>Tuebingen</city>
        <zip>72074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barabar Schlisio, Dr. med</last_name>
      <phone>07071/2985612</phone>
      <email>barbara.schlisio@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2017</study_first_submitted>
  <study_first_submitted_qc>November 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2017</study_first_posted>
  <last_update_submitted>November 27, 2017</last_update_submitted>
  <last_update_submitted_qc>November 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Zalviso</keyword>
  <keyword>sufentanyl</keyword>
  <keyword>PCA</keyword>
  <keyword>Dipidolor</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

